Santhera Pharmaceuticals Holding AG (XSWX:SANN) 3-Year EBITDA Growth Rate : 1.00% (As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG 3-Year EBITDA Growth Rate?

Santhera Pharmaceuticals Holding AG's EBITDA per Share for the six months ended in Jun. 2023 was CHF-1.22.

During the past 3 years, the average EBITDA Per Share Growth Rate was 1.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 36.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Santhera Pharmaceuticals Holding AG was 56.60% per year. The lowest was -61.30% per year. And the median was 20.10% per year.

Competitive Comparison of Santhera Pharmaceuticals Holding AG's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santhera Pharmaceuticals Holding AG's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's 3-Year EBITDA Growth Rate falls into.

Santhera Pharmaceuticals Holding AG 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Santhera Pharmaceuticals Holding AG 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (XSWX:SANN) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SPHDF:USA SANNz:UK

Address

Hohenrainstrasse 24, Pratteln, CHE, 4133

Website

https://www.santhera.com

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Headlines

No Headlines